Fulminant hepatic failure resulting from small-cell lung cancer and dramatic response of chemotherapy

World J Gastroenterol. 2006 Apr 21;12(15):2466-8. doi: 10.3748/wjg.v12.i15.2466.

Abstract

Prompt treatment in tumor-associated encephalopathy may prolong survival. We describe a 69-year-old male patient who was presented with fulminant hepatic failure, secondary to small-cell lung carcinoma with rapidly progressing encephalopathy. Both symptoms remitted following chemotherapy, suggesting swift diagnosis and administration of chemotherapy to be effective in treatment of fulminant hepatic failure and encephalopathy.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antineoplastic Agents / therapeutic use
  • Carcinoma, Small Cell / complications*
  • Carcinoma, Small Cell / drug therapy*
  • Carcinoma, Small Cell / secondary
  • Humans
  • Liver Failure, Acute / drug therapy*
  • Liver Failure, Acute / etiology*
  • Liver Neoplasms / secondary
  • Lung Neoplasms / complications*
  • Lung Neoplasms / drug therapy*
  • Male

Substances

  • Antineoplastic Agents